QUELLIS BIOSCIENCES
Quellis Biosciences is dedicated to improving the lives of patients suffering from serious rare diseases by developing next-generation antibody therapies that deliver value by improving patient outcomes.Quellis was founded to deliver best-in-class therapies to patients suffering serious rare diseases โ and underserved by current treatment options.
QUELLIS BIOSCIENCES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-11-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.quellisbio.com
Total Employee:
501+
Status:
Closed
Contact:
(267) 760-4066
Total Funding:
17 M USD
Technology used in webpage:
SPF Content Delivery Network Apache Amazon CloudFront AWS Global Accelerator Symantec Secure Site Bodis Sedo Hosting Above
Current Employees Featured
Founder
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series A - Quellis Biosciences
Viridian Biosciences
Viridian Biosciences investment in Series A - Quellis Biosciences
Official Site Inspections
http://www.quellisbio.com
- Host name: 172.67.179.156
- IP address: 172.67.179.156
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Quellis Biosciences"
Quellis Biosciences - Crunchbase Company Profile
Quellis Biosciences is dedicated to improving the lives of patients suffering from serious rare diseases by developing next-generation antibody therapies that โฆSee details»
Quellis Biosciences Company Profile | Management and
Www.quellisbio.com Quellis Biosciences Profile and History Founded in 2017 and based in Boston, Quellis Biosciences is dedicated to improving the lives of patients suffering from โฆSee details»
Quellis Biosciences - PitchBook
Quellis Biosciences General Information Description. Developer of biopharmaceuticals focused on discovering new molecules to treat rare diseases. The company's services include developing โฆSee details»
Quellis Biosciences - Craft
Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases. The company aims to improve the lives of patients by developing antibody โฆSee details»
Quellis Biosciences - Overview, News & Similar companies
Jan 28, 2021 Who is Quellis Biosciences. Founded in 2017 and based in Boston, Quellis Biosciences is dedicated to improving the lives of patients suffering from serious rare diseases โฆSee details»
Quellis Biosciences - Company Profile - Tracxn
Feb 22, 2025 Quellis Biosciences - Deveoper of antibody-based drugs for rare diseases. Acquired by Astria. Raised a total funding of $17M over 2 rounds from 1 investor. Founded by โฆSee details»
Quellis Biosciences | VentureRadar
Website: http://www.quellisbio.com/ Develops novel monoclonal antibody therapies targeting life-threatening rare diseases, with a focus on optimizing treatment ...See details»
Quellis Biosciences - Products, Competitors, Financials, Employees ...
Quellis Biosciences is dedicated to improving the lives of patients suffering from serious rare diseases by developing next-generation antibody therapies that deliver value by improving โฆSee details»
Quellis Biosciences LLC - Drug pipelines, Patents, Clinical trials ...
Explore Quellis Biosciences LLC with its drug pipeline, therapeutic area, technology platform, 8 news, and 1 literature.See details»
Quellis Biosciences - Funding, Financials, Valuation & Investors
Quellis Biosciences is an emerging biopharmaceutical company focused on discovering best-in-class new molecules.See details»
Quellis Biosciences - Ownership and Business Overview - Mergr
Jan 29, 2021 Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021.The largest life science acquisition in 2021 was Pharmaceutical Product Development โฆSee details»
Quellis Biosciences, Inc. | Golden
Quellis Biosciences, Inc. is a Waltham, Massachusetts-based company founded in 2017. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Quellis Biosciences-ๅจ่็ฝ - vbdata.cn
Quellis Biosciences่ดๅไบๆนๅๆฃๆไธฅ้็ฝ่ง็พ็ ็ๆฃ่ ็็ๆดป๏ผ้่ฟๅผๅๆฐไธไปฃๆไฝ็ๆณ๏ผ้่ฟๆนๅๆฃ่ ็็ปๆๆไพไปทๅผใQuellis็ๆ็ซๆฏไธบไบๅๆฃๆไธฅ้็ฝ่ง็พ็ ็ๆฃ่ ๆไพๆๅฅฝ็ๆฒป็ๆน โฆSee details»
Catabasis Pharmaceuticals Announces Acquisition of Quellis โฆ
Management and Organization Catabasis will continue to be led by its current management team consisting of Jill C. Milne, Ph.D., Chief Executive Officer, Noah Clauser, Chief Financial โฆSee details»
Astria Therapeutics acquires Quellis Biosciences - 2021-01-29 ...
Jan 29, 2021 Acquired Organization: Quellis Biosciences Quellis Biosciences is an emerging biopharmaceutical company focused on discovering best-in-class new molecules. Acquiring โฆSee details»
Quellis Biosciences - Biotech Careers
The lead Quellis program targets a life-threatening rare disease. The Company is currently optimizing several new monoclonal antibodies (mAbs) for use in treatment. Business Areas: โฆSee details»
Quellis Biosciences Stock Price, Funding, Valuation, Revenue ...
See Quellis Biosciences funding rounds, investors, investments, exits and more. Evaluate their financials based on Quellis Biosciences's post-money valuation and revenue.See details»
Quellis Biosciences Inc. Announces $17 Million Series A Financing
Dec 10, 2019 For more information, see www.quellisbio.com About Perceptive Xontogeny Venture Fund Established in 2018, the Perceptive Xontogeny Venture Fund (PXV Fund) โฆSee details»
Quellis Biosciences CEO, Founder, Key Executive Team, Board of ...
Explore {Quellis Biosciences's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Contacts, Employees, Board Members, Advisors & Alumni
Quellis Biosciences is an emerging biopharmaceutical company focused on discovering best-in-class new molecules.See details»